Georg Duftschmid
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Georg Duftschmid has a total of 74 co-authors. Here are the top co-authors by number of shared publications:
- Christoph Rinner
Center for Medical Statistics, Informatics and Intelligent Systems (CeMSIIS), Medical University of Vienna, Vienna, Austria
9 shared publications - Florian Katsch
Institute of Medical Information Management, Center for Medical Data Science, Medical University of Vienna, Vienna, Austria
3 shared publications - Gottfried Endel
Austrian Social Insurance (Dachverband der Sozialversicherungen), Vienna, Austria
3 shared publications - Peter Klimek
Complexity Science Hub Vienna, Vienna, Austria
3 shared publications - Adnan Jouned
Institute of Medical Information Management, Center for Medical Data Science, Medical University of Vienna, Vienna, Austria
2 shared publications - Christoph Mitsch
From the Department of Neurology (G.B., N.K., K.R., P.A., B.K., F.L., S.M., P.P., P.S.R., G.Z., T.B.), Medical University of Vienna; and Department of Ophthalmology (C.M., B.P.), Medical University of Vienna, Austria
2 shared publications
Latest Publications
- 3 September 2026
- Published by Springer Nature
- p. 465-472
Beyond Component Failure: Systems-Theoretic Analysis of Interaction Hazards in Standards-Based Clinical Decision Support
- 3 September 2026
- Published by Springer Nature
- p. 465-472
Beyond Component Failure: Systems-Theoretic Analysis of Interaction Hazards in Standards-Based Clinical Decision Support
- Open Access
- 29 June 2026
- Published by IOS Press
- Vol. 338, 1-5
SyntheaWeb: A Web-Based Platform for the Generation and Interactive Inspection of Synthetic Healthcare Data
Access to real-world healthcare data is increasingly hindered by privacy concerns and stringent legal frameworks, including the General Data Protection Regulation (GDPR) and the Health Insurance Portability and Accountability Act (HIPAA). Consequently, synthetic healthcare data generators, notably Synthea™, have emerged as essential tools to generate high-quality datasets with minimal privacy and legal concerns. However, many simulation engines including, Synthea™, predominantly rely on command-line interfaces (CLI), imposing significant technical barriers for clinical researchers. Furthermore, raw output formats such as HL7 Fast Healthcare Interoperability Resources (FHIR) JSON create a substantial “interpretability gap” for end-users. To address these challenges, we present SyntheaWeb, a web-based platform that simplifies the generation and interactive inspection of synthetic patient cohorts. It provides a user interface, visual cohort dashboard, structured longitudinal patient records, semantic terminology linking (e.g., SNOMED CT, LOINC), and the capability for selective subset export.
- 29 June 2026
- Published by IOS Press
- Vol. 338, 1-5
Open AccessSyntheaWeb: A Web-Based Platform for the Generation and Interactive Inspection of Synthetic Healthcare Data
Access to real-world healthcare data is increasingly hindered by privacy concerns and stringent legal frameworks, including the General Data Protection Regulation (GDPR) and the Health Insurance Portability and Accountability Act (HIPAA). Consequently, synthetic healthcare data generators, notably Synthea™, have emerged as essential tools to generate high-quality datasets with minimal privacy and legal concerns. However, many simulation engines including, Synthea™, predominantly rely on command-line interfaces (CLI), imposing significant technical barriers for clinical researchers. Furthermore, raw output formats such as HL7 Fast Healthcare Interoperability Resources (FHIR) JSON create a substantial “interpretability gap” for end-users. To address these challenges, we present SyntheaWeb, a web-based platform that simplifies the generation and interactive inspection of synthetic patient cohorts. It provides a user interface, visual cohort dashboard, structured longitudinal patient records, semantic terminology linking (e.g., SNOMED CT, LOINC), and the capability for selective subset export.
- Open Access
- 26 June 2025
- Published by IOS Press
- Vol. 328, 382-386
Bridging the Legacy Interoperability Gap: A Flexible Approach to Implementing a FHIR Facade for EAV-Based Health Information Systems
Interoperability in healthcare information systems is crucial for seamless data exchange. Legacy systems often employ the Entity-Attribute-Value (EAV) model, which poses significant challenges for data standardization and integration with modern frameworks like HL7 Fast Healthcare Interoperability Resources (FHIR). This paper presents an easily reusable open-source implementation of a FHIR façade for EAV-based legacy health information systems based on HAPI FHIR. The proposed methodology separates the mapping logic from the implementation code, allowing for easier maintenance and updates. We demonstrate how this approach addresses key challenges in transforming legacy EAV data to FHIR resources, particularly focusing on the management of multiple source forms and the need for a maintainable solution. Initial results show that the approach is effective, achieving high accuracy in data transformation while maintaining system stability and ease of maintenance.
- 26 June 2025
- Published by IOS Press
- Vol. 328, 382-386
Open AccessBridging the Legacy Interoperability Gap: A Flexible Approach to Implementing a FHIR Facade for EAV-Based Health Information Systems
Interoperability in healthcare information systems is crucial for seamless data exchange. Legacy systems often employ the Entity-Attribute-Value (EAV) model, which poses significant challenges for data standardization and integration with modern frameworks like HL7 Fast Healthcare Interoperability Resources (FHIR). This paper presents an easily reusable open-source implementation of a FHIR façade for EAV-based legacy health information systems based on HAPI FHIR. The proposed methodology separates the mapping logic from the implementation code, allowing for easier maintenance and updates. We demonstrate how this approach addresses key challenges in transforming legacy EAV data to FHIR resources, particularly focusing on the management of multiple source forms and the need for a maintainable solution. Initial results show that the approach is effective, achieving high accuracy in data transformation while maintaining system stability and ease of maintenance.
- Open Access
- 6 March 2025
- Published by Oxford University Press (OUP) in JAMIA Open
- Vol. 8 (2) , ooaf022
Converting Health Level 7 Clinical Document Architecture (CDA) documents to Observational Medical Outcomes Partnership Common Data Model (OMOP CDM) by leveraging CDA Template definitions
Objectives: This work aims to develop a methodology for transforming Health Level 7 (HL7) Clinical Document Architecture (CDA) documents into the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM). The described method seeks to improve the Extract, Transform, Load (ETL) design process by using HL7 CDA Template definitions and the CDA Refined Message Information Model (CDA R-MIM). Material and Methods: Our approach utilizes HL7 CDA Templates to define structural and semantic mappings. Supported by the CDA R-MIM for semantic alignment with the OMOP CDM, we developed a tool named CDA Rabbit that enables the generation of Rabbit-In-a-Hat project files from HL7 CDA Template definitions and could be successfully integrated into the existing toolchain around OMOP. Results: We tested our approach using 13 CDA Templates from the Austrian national EHR System (ELGA) and 430 anonymized CDA test documents that were mapped to 10 OMOP CDM tables. The data quality assessment, using OMOP’s DataQualityDashboard, showed a 99% pass rate, indicating a robust and accurate data transformation. Conclusion: This study presents a novel framework for transforming HL7 CDA documents into OMOP CDM using template definitions and CDA R-MIM. The methodology improves semantic interoperability, mapping reusability, and ETL design efficiency. Future work should focus on automating code generation, improving data profiling, and addressing cyclic dependencies within CDA templates. The presented approach supports improved secondary use of health data and research while adhering to standardized data models and semantics. Discussion: Using CDA Templates for ETL design addresses common ETL challenges, such as data accessibility during ETL design, by decoupling the process from the actual CDA instances. Future work could focus on extending this approach to automatically generate boilerplate code, address cyclic dependencies within CDA Templates, and adapt the method for the use with FHIR profiles.
- 6 March 2025
- Published by Oxford University Press (OUP) in JAMIA Open
- Vol. 8 (2) , ooaf022
Open AccessConverting Health Level 7 Clinical Document Architecture (CDA) documents to Observational Medical Outcomes Partnership Common Data Model (OMOP CDM) by leveraging CDA Template definitions
Objectives: This work aims to develop a methodology for transforming Health Level 7 (HL7) Clinical Document Architecture (CDA) documents into the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM). The described method seeks to improve the Extract, Transform, Load (ETL) design process by using HL7 CDA Template definitions and the CDA Refined Message Information Model (CDA R-MIM). Material and Methods: Our approach utilizes HL7 CDA Templates to define structural and semantic mappings. Supported by the CDA R-MIM for semantic alignment with the OMOP CDM, we developed a tool named CDA Rabbit that enables the generation of Rabbit-In-a-Hat project files from HL7 CDA Template definitions and could be successfully integrated into the existing toolchain around OMOP. Results: We tested our approach using 13 CDA Templates from the Austrian national EHR System (ELGA) and 430 anonymized CDA test documents that were mapped to 10 OMOP CDM tables. The data quality assessment, using OMOP’s DataQualityDashboard, showed a 99% pass rate, indicating a robust and accurate data transformation. Conclusion: This study presents a novel framework for transforming HL7 CDA documents into OMOP CDM using template definitions and CDA R-MIM. The methodology improves semantic interoperability, mapping reusability, and ETL design efficiency. Future work should focus on automating code generation, improving data profiling, and addressing cyclic dependencies within CDA templates. The presented approach supports improved secondary use of health data and research while adhering to standardized data models and semantics. Discussion: Using CDA Templates for ETL design addresses common ETL challenges, such as data accessibility during ETL design, by decoupling the process from the actual CDA instances. Future work could focus on extending this approach to automatically generate boilerplate code, address cyclic dependencies within CDA Templates, and adapt the method for the use with FHIR profiles.
- 17 February 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Journal of Biomedical and Health Informatics
- Vol. 29 (5) , 3712-3722
Comparison of Electronic Prescription Systems in the European Union: Benchmarking Development, Use, and Future Trends
While Electronic Prescription Systems (EPS) adoption varies across EU Member States, there's a lack of comprehensive comparative analysis. Existing studies focus on single EPSs, employ diverse methodologies, and lack up-to-date data. This study fills this gap by providing a comprehensive overview of EPS development, functionalities, and usage statistics in each EU Member State. Most EU Member States widely adopted EPS by 2022, with exceptions including Germany, France, and Luxembourg, where pilot projects or just plans existed at that time. Out of the 27 EPSs, 25 employ a similar design featuring a central server and end-user software or web-based applications. Among these, 22 are structured as single national systems. The fundamental technical solution is remarkably similar across the EU. Despite these similarities, functionalities, authentication methods, prescription validity, and medication coverage differ significantly among EPSs. A multinational team, including co-authors from each EU Member State, collected data using a structured questionnaire. The study underscores the need for standardized methodologies in EPS research and emphasizes the importance of comprehensive comparative analysis to inform healthcare policies and digitalization efforts.
- 17 February 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Journal of Biomedical and Health Informatics
- Vol. 29 (5) , 3712-3722
Comparison of Electronic Prescription Systems in the European Union: Benchmarking Development, Use, and Future Trends
While Electronic Prescription Systems (EPS) adoption varies across EU Member States, there's a lack of comprehensive comparative analysis. Existing studies focus on single EPSs, employ diverse methodologies, and lack up-to-date data. This study fills this gap by providing a comprehensive overview of EPS development, functionalities, and usage statistics in each EU Member State. Most EU Member States widely adopted EPS by 2022, with exceptions including Germany, France, and Luxembourg, where pilot projects or just plans existed at that time. Out of the 27 EPSs, 25 employ a similar design featuring a central server and end-user software or web-based applications. Among these, 22 are structured as single national systems. The fundamental technical solution is remarkably similar across the EU. Despite these similarities, functionalities, authentication methods, prescription validity, and medication coverage differ significantly among EPSs. A multinational team, including co-authors from each EU Member State, collected data using a structured questionnaire. The study underscores the need for standardized methodologies in EPS research and emphasizes the importance of comprehensive comparative analysis to inform healthcare policies and digitalization efforts.
- Open Access
- 1 January 2020
- Published by IOS Press
- Vol. 271, 17-22
Reusing Data of an EU-Wide EHR System for Clinical Trials: A Capabilities Analysis
Conduction of clinical trials may benefit from the reuse of EHR data. The upcoming EHR system eHDSI provides data exchange between European countries and thus represents an attractive data source for multinational trials. In this paper we analyze to what extent eHDSI could provide data relevant for trials with a focus on patient recruitment. Data elements identified in the EHR4CR project to be frequently used in trials were mapped to the HL7 templates of the eHDSI document types using the open source tool ART-DECOR. From the 149 EHR4CR data elements, 44 (30%) could be mapped to eHDSI document components. Despite this moderate coverage, eHDSI could still provide a substantial contribution for recruitment by an automatic pre-filtering process of large groups of potential trial candidates.
- 1 January 2020
- Published by IOS Press
- Vol. 271, 17-22
Open AccessReusing Data of an EU-Wide EHR System for Clinical Trials: A Capabilities Analysis
Conduction of clinical trials may benefit from the reuse of EHR data. The upcoming EHR system eHDSI provides data exchange between European countries and thus represents an attractive data source for multinational trials. In this paper we analyze to what extent eHDSI could provide data relevant for trials with a focus on patient recruitment. Data elements identified in the EHR4CR project to be frequently used in trials were mapped to the HL7 templates of the eHDSI document types using the open source tool ART-DECOR. From the 149 EHR4CR data elements, 44 (30%) could be mapped to eHDSI document components. Despite this moderate coverage, eHDSI could still provide a substantial contribution for recruitment by an automatic pre-filtering process of large groups of potential trial candidates.
- Open Access
- 12 April 2019
- Published by JMIR Publications Inc. in JMIR Medical Informatics
- Vol. 7 (2) , e12172-171
Patient-Sharing Relations in the Treatment of Diabetes and Their Implications for Health Information Exchange: Claims-Based Analysis
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Health information exchange (HIE) between care providers who cooperate in the treatment of patients with diabetes mellitus (DM) has been rated as an important aspect of successful care. Patient-sharing relations between care providers permit inferences about corresponding information-sharing relations. Objective: By analyzing patient-sharing relations between various types of care providers (ToCPs) - such as hospitals, pharmacies and different outpatient specialists - within a nationwide claims dataset of Austrian DM patients, we aimed to obtain information for an effective design of HIE platforms to be used in DM care. We focus on two parameters derived from patient-sharing networks: (i) the principal HIE partners of the different ToCPs involved in the treatment of DM, and (ii) the required participation rate of ToCPs in HIE platforms for the purpose of effective communication. Methods: Claims data of 7.9 million Austrian patients from 2006 and 2007 served as our data source. DM patients were identified by their medication. We established metrics for the quantification of our two parameters of interest. The principal HIE partners are derived from the portions of a care provider’s patient-sharing relations with different ToCPs. For the required participation rate of ToCPs in an HIE platform, we determine the concentration of patient-sharing relations between ToCPs. Our corresponding metrics are derived in analogy from existing work for the quantification of the continuity of care. Results: We identified 324,703 DM patients treated by 12,226 care providers; the latter were members of 16 ToCPs. Based on their score for our two parameters, we categorized the ToCPs into “low”, “medium”, and “high”. For the parameter named “most important HIE partner”, pharmacies, general practitioners (GPs), and laboratories were the representatives of the top group, i.e. our care providers shared the highest numbers of DM patients with these ToCPs. Concerning the parameter “required participation rate of ToCP in HIE platform”, the concentration of DM patient-sharing relations with a ToCP tended to be inversely related to the ToCP’s member count. Conclusions: We conclude that GPs, pharmacies, and laboratories should be core members of any HIE platform that supports DM care, as they are the most important DM patient-sharing partners. We further conclude that, for implementing HIE with ToCPs that have many members (in Austria particularly GPs and pharmacies), an HIE solution with high participation rates of these ToCPs (ideally a nationwide HIE platform with obligatory participation of the concerned ToCPs) seems essential. This will raise the probability of HIE being achieved with any care provider of these ToCPs. As chronic diseases are rising due to aging societies, we believe that our quantification of HIE requirements in the treatment of DM can provide valuable insights for many industrial countries.
- 12 April 2019
- Published by JMIR Publications Inc. in JMIR Medical Informatics
- Vol. 7 (2) , e12172-171
Open AccessPatient-Sharing Relations in the Treatment of Diabetes and Their Implications for Health Information Exchange: Claims-Based Analysis
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Health information exchange (HIE) between care providers who cooperate in the treatment of patients with diabetes mellitus (DM) has been rated as an important aspect of successful care. Patient-sharing relations between care providers permit inferences about corresponding information-sharing relations. Objective: By analyzing patient-sharing relations between various types of care providers (ToCPs) - such as hospitals, pharmacies and different outpatient specialists - within a nationwide claims dataset of Austrian DM patients, we aimed to obtain information for an effective design of HIE platforms to be used in DM care. We focus on two parameters derived from patient-sharing networks: (i) the principal HIE partners of the different ToCPs involved in the treatment of DM, and (ii) the required participation rate of ToCPs in HIE platforms for the purpose of effective communication. Methods: Claims data of 7.9 million Austrian patients from 2006 and 2007 served as our data source. DM patients were identified by their medication. We established metrics for the quantification of our two parameters of interest. The principal HIE partners are derived from the portions of a care provider’s patient-sharing relations with different ToCPs. For the required participation rate of ToCPs in an HIE platform, we determine the concentration of patient-sharing relations between ToCPs. Our corresponding metrics are derived in analogy from existing work for the quantification of the continuity of care. Results: We identified 324,703 DM patients treated by 12,226 care providers; the latter were members of 16 ToCPs. Based on their score for our two parameters, we categorized the ToCPs into “low”, “medium”, and “high”. For the parameter named “most important HIE partner”, pharmacies, general practitioners (GPs), and laboratories were the representatives of the top group, i.e. our care providers shared the highest numbers of DM patients with these ToCPs. Concerning the parameter “required participation rate of ToCP in HIE platform”, the concentration of DM patient-sharing relations with a ToCP tended to be inversely related to the ToCP’s member count. Conclusions: We conclude that GPs, pharmacies, and laboratories should be core members of any HIE platform that supports DM care, as they are the most important DM patient-sharing partners. We further conclude that, for implementing HIE with ToCPs that have many members (in Austria particularly GPs and pharmacies), an HIE solution with high participation rates of these ToCPs (ideally a nationwide HIE platform with obligatory participation of the concerned ToCPs) seems essential. This will raise the probability of HIE being achieved with any care provider of these ToCPs. As chronic diseases are rising due to aging societies, we believe that our quantification of HIE requirements in the treatment of DM can provide valuable insights for many industrial countries.
- Open Access
- 29 January 2019
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 19 (1) , 1-10
Readiness to use telemonitoring in diabetes care: a cross-sectional study among Austrian practitioners
Telemonitoring services could dramatically improve the care of diabetes patients by enhancing their quality of life while decreasing healthcare expenditures. However, the potential for implementing innovative treatment options in the Austrian public and private health system is not known yet. Thus, we analyzed the readiness to use telemonitoring in diabetes care among Austrian practitioners. We conducted an online survey among a purposive sample of Austrian practitioners (n = 41) using an adapted German version of the practitioner telehealth readiness assessment tool. We assessed three readiness domains for telemonitoring in the context of diabetes care, i.e. core readiness, engagement readiness, and structural readiness, and validated the German tool using principal components analysis. Study subjects perceived themselves as open to innovations and also expressed optimistic attitudes towards telemonitoring in general and offering telemonitoring-based services for their patients. Participants achieved a medium average readiness level for telemonitoring (58.2, 95% CI 53.9–62.5) and were thus in a good position to use telemonitoring, although some arguments may adversely affected its use. The top three perceived benefits of telemonitoring were enhanced quality of treatment, better therapy adjustment, and reduced travel and waiting times for patients. The top three barriers were reduced personal communication, practitioner time expenditure and equally placed poor financial compensation as well as data security and privacy issues. Our data revealed that Austrian practitioners showed a quite moderate readiness to use telemonitoring in diabetes care. To further advance telemonitoring readiness among all pillars of diabetes care in Austria, joint efforts among healthcare stakeholders are required to overcome existing financial, organizational, and technical obstacles.
- 29 January 2019
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 19 (1) , 1-10
Open AccessReadiness to use telemonitoring in diabetes care: a cross-sectional study among Austrian practitioners
Telemonitoring services could dramatically improve the care of diabetes patients by enhancing their quality of life while decreasing healthcare expenditures. However, the potential for implementing innovative treatment options in the Austrian public and private health system is not known yet. Thus, we analyzed the readiness to use telemonitoring in diabetes care among Austrian practitioners. We conducted an online survey among a purposive sample of Austrian practitioners (n = 41) using an adapted German version of the practitioner telehealth readiness assessment tool. We assessed three readiness domains for telemonitoring in the context of diabetes care, i.e. core readiness, engagement readiness, and structural readiness, and validated the German tool using principal components analysis. Study subjects perceived themselves as open to innovations and also expressed optimistic attitudes towards telemonitoring in general and offering telemonitoring-based services for their patients. Participants achieved a medium average readiness level for telemonitoring (58.2, 95% CI 53.9–62.5) and were thus in a good position to use telemonitoring, although some arguments may adversely affected its use. The top three perceived benefits of telemonitoring were enhanced quality of treatment, better therapy adjustment, and reduced travel and waiting times for patients. The top three barriers were reduced personal communication, practitioner time expenditure and equally placed poor financial compensation as well as data security and privacy issues. Our data revealed that Austrian practitioners showed a quite moderate readiness to use telemonitoring in diabetes care. To further advance telemonitoring readiness among all pillars of diabetes care in Austria, joint efforts among healthcare stakeholders are required to overcome existing financial, organizational, and technical obstacles.
- Open Access
- 11 September 2018
- Published by JMIR Publications Inc. in JMIR Preprints
Patient-Sharing Relations in the Treatment of Diabetes and Their Implications for Health Information Exchange: Claims-Based Analysis (Preprint)
BACKGROUND Health information exchange (HIE) among care providers who cooperate in the treatment of patients with diabetes mellitus (DM) has been rated as an important aspect of successful care. Patient-sharing relations among care providers permit inferences about corresponding information-sharing relations. OBJECTIVES This study aimed to obtain information for an effective HIE platform design to be used in DM care by analyzing patient-sharing relations among various types of care providers (ToCPs), such as hospitals, pharmacies, and different outpatient specialists, within a nationwide claims dataset of Austrian DM patients. We focus on 2 parameters derived from patient-sharing networks: (1) the principal HIE partners of the different ToCPs involved in the treatment of DM and (2) the required participation rate of ToCPs in HIE platforms for the purpose of effective communication. METHODS The claims data of 7.9 million Austrian patients from 2006 to 2007 served as our data source. DM patients were identified by their medication. We established metrics for the quantification of our 2 parameters of interest. The principal HIE partners were derived from the portions of a care provider’s patient-sharing relations with different ToCPs. For the required participation rate of ToCPs in an HIE platform, we determine the concentration of patient-sharing relations among ToCPs. Our corresponding metrics are derived in analogy from existing work for the quantification of the continuity of care. RESULTS We identified 324,703 DM patients treated by 12,226 care providers; the latter were members of 16 ToCPs. On the basis of their score for 2 of our parameters, we categorized the ToCPs into low, medium, and high. For the most important HIE partner parameter, pharmacies, general practitioners (GPs), and laboratories were the representatives of the top group, that is, our care providers shared the highest numbers of DM patients with these ToCPs. For the required participation rate of type of care provide (ToCP) in HIE platform parameter, the concentration of DM patient-sharing relations with a ToCP tended to be inversely related to the ToCPs member count. CONCLUSIONS We conclude that GPs, pharmacies, and laboratories should be core members of any HIE platform that supports DM care, as they are the most important DM patient-sharing partners. We further conclude that, for implementing HIE with ToCPs who have many members (in Austria, particularly GPs and pharmacies), an HIE solution with high participation rates from these ToCPs (ideally a nationwide HIE platform with obligatory participation of the concerned ToCPs) seems essential. This will raise the probability of HIE being achieved with any care provider of these ToCPs. As chronic diseases are rising because of aging societies, we believe that our quantification of HIE requirements in the treatment of DM can provide valuable insights for many industrial countries.
- 11 September 2018
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessPatient-Sharing Relations in the Treatment of Diabetes and Their Implications for Health Information Exchange: Claims-Based Analysis (Preprint)
BACKGROUND Health information exchange (HIE) among care providers who cooperate in the treatment of patients with diabetes mellitus (DM) has been rated as an important aspect of successful care. Patient-sharing relations among care providers permit inferences about corresponding information-sharing relations. OBJECTIVES This study aimed to obtain information for an effective HIE platform design to be used in DM care by analyzing patient-sharing relations among various types of care providers (ToCPs), such as hospitals, pharmacies, and different outpatient specialists, within a nationwide claims dataset of Austrian DM patients. We focus on 2 parameters derived from patient-sharing networks: (1) the principal HIE partners of the different ToCPs involved in the treatment of DM and (2) the required participation rate of ToCPs in HIE platforms for the purpose of effective communication. METHODS The claims data of 7.9 million Austrian patients from 2006 to 2007 served as our data source. DM patients were identified by their medication. We established metrics for the quantification of our 2 parameters of interest. The principal HIE partners were derived from the portions of a care provider’s patient-sharing relations with different ToCPs. For the required participation rate of ToCPs in an HIE platform, we determine the concentration of patient-sharing relations among ToCPs. Our corresponding metrics are derived in analogy from existing work for the quantification of the continuity of care. RESULTS We identified 324,703 DM patients treated by 12,226 care providers; the latter were members of 16 ToCPs. On the basis of their score for 2 of our parameters, we categorized the ToCPs into low, medium, and high. For the most important HIE partner parameter, pharmacies, general practitioners (GPs), and laboratories were the representatives of the top group, that is, our care providers shared the highest numbers of DM patients with these ToCPs. For the required participation rate of type of care provide (ToCP) in HIE platform parameter, the concentration of DM patient-sharing relations with a ToCP tended to be inversely related to the ToCPs member count. CONCLUSIONS We conclude that GPs, pharmacies, and laboratories should be core members of any HIE platform that supports DM care, as they are the most important DM patient-sharing partners. We further conclude that, for implementing HIE with ToCPs who have many members (in Austria, particularly GPs and pharmacies), an HIE solution with high participation rates from these ToCPs (ideally a nationwide HIE platform with obligatory participation of the concerned ToCPs) seems essential. This will raise the probability of HIE being achieved with any care provider of these ToCPs. As chronic diseases are rising because of aging societies, we believe that our quantification of HIE requirements in the treatment of DM can provide valuable insights for many industrial countries.
- Open Access
- 9 May 2016
- Published by Elsevier in International Journal of Medical Informatics
- Vol. 92, 44-53
Improving the informational continuity of care in diabetes mellitus treatment with a nationwide Shared EHR system: Estimates from Austrian claims data
- 9 May 2016
- Published by Elsevier in International Journal of Medical Informatics
- Vol. 92, 44-53
Open AccessImproving the informational continuity of care in diabetes mellitus treatment with a nationwide Shared EHR system: Estimates from Austrian claims data